510(k) Report

510(k) · Cleared

Cleared

Optetrak Logic Porous Femoral Components

K140302510(k) TraditionalCleared Jul 30, 2014174-day reviewClass II21 CFR 888.3565

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Exactech, Inc. · MBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer

Cleared on Jul 30, 2014 as substantially equivalent to K123687 (Exactech, Inc., 2013) and 1 other predicate after a 174-day review. Its family tree reaches back 8 generations to 1994. 1 later device descends from it.

Decided
Jul 30, 2014
Review
174 days
Class
Class II
Product code
MBH
Recalls
None
Predicates
2

Its longest line of descent runs back 8 generations to K936079 (1994). 21 ancestors in all, the oldest K933787 (1994). 1 later device descends from it, 1 citing it directly.

  1. Root · 8 generations backK936079 Ecactech Porous Coated Finned Tibial Tray CompnentExactech, Inc. · 1994
  2. 7 generations backK011976 Optetrak Total Knee System Size 0/1 Delta (Line Extension)Exactech, Inc. · 2001
  3. 6 generations backK032606 Optetrak Total Knee System Asymmetric Femoral Components Size 6…Exactech, Inc. · 2003
  4. 5 generations backK033883 Optetrak Total Knee System, HI-Flex Asymmetric Posterior-Stabilized…Exactech, Inc. · 2004 · Recalled
  5. 4 generations backK093360 Optetrak Logic Total Knee System Trapezoidal Tibial Tray, Sizes…Exactech, Inc. · 2010 · Recalled
  6. 3 generations backK111400 Optetrak Logic CR Tibial Insert, Optetrak Logic CR Femoral ComponentExactech, Inc. · 2011 · Recalled
  7. 2 generations backK121307 Optetrak Logic CR Tibial Insert, Size 0 Optetrak Logic CR Tibial…Exactech, Inc. · 2012
  8. 1 generation backK123687 Optetrak Logic Porous Femoral ComponentExactech, Inc. · 2013
  9. This deviceK140302 Optetrak Logic Porous Femoral ComponentsExactech, Inc. · 2014
  10. Descendant · cites it directly · 0 of its ownK181794 Truliant Porous Femoral ComponentsExactech, Inc. · 2018

Most influential descendants

Showing 1 of 1 · See all
  • K181794Truliant Porous Femoral ComponentsExactech, Inc. · 2018 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K936079Ecactech Porous Coated Finned Tibial Tray CompnentExactech, Inc.1994—
−7K011976Optetrak Total Knee System Size 0/1 Delta (Line Extension)Exactech, Inc.2001—
−6K032606Optetrak Total Knee System Asymmetric Femoral Components Size 6…Exactech, Inc.2003—
−5K033883Optetrak Total Knee System, HI-Flex Asymmetric Posterior-Stabilized Cemented…Exactech, Inc.20043
−4K093360Optetrak Logic Total Knee System Trapezoidal Tibial Tray, Sizes…Exactech, Inc.20102
−3K111400Optetrak Logic CR Tibial Insert, Optetrak Logic CR Femoral ComponentExactech, Inc.20111
−2K121307Optetrak Logic CR Tibial Insert, Size 0 Optetrak Logic CR Tibial Insert, Size…Exactech, Inc.2012—
−1K123687Optetrak Logic Porous Femoral ComponentExactech, Inc.2013—
0 (this device)K140302Optetrak Logic Porous Femoral ComponentsExactech, Inc.2014—
+1K181794Truliant Porous Femoral ComponentsExactech, Inc.2018—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199450
199530
199620
200110
200610
200810

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201810
FIG. 1 — Lineage of K140302, 1994–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MBH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MBH device

  1. #1 K241597 Freedom® Total Knee System - Porous Tibial…score 19.9 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K123687Optetrak Logic Porous Femoral Component
Summary page 1
…WH, MBH Information on devices to which substantial equivalence is claimed: 5 10(k) Trade or Proprietary or Model Name Manufacturer K 123687 Optetrak Logic Porous Femoral Components Exactech, Inc K062654 Sigma CR Porocoat®D Femoral Compo…
Exactech, Inc.2013—
*K062654Depuy Sigma Cruciate Retaining Porocoat Femoral Components
Summary page 1
…de or Proprietary or Model Name Manufacturer K 123687 Optetrak Logic Porous Femoral Components Exactech, Inc K062654 Sigma CR Porocoat®D Femoral Components DePuy Indications for Use: The OPTETRLAK Comprehensive Kn…
DePuy Orthopaedics, Inc.2006—

Also cleared against K123687: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K181794Truliant Porous Femoral ComponentsExactech, Inc.20180

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 1 company; a new generation was cleared every 1.5 years on median.
  • 11 of the 21 ancestors have a recall of any class.
  • Of its descendants, K181794 (Exactech, Inc., 2018) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K123687.

How does its category compare?

All MBH devices

MBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · MBH

8in 2025

2007: 102008: 32009: 32010: 42011: 52012: 52013: 62014: 92015: 82016: 42017: 42018: 62019: 12020: 72021: 62022: 72023: 62024: 102025: 82026 (partial year): 7
2007high 10 (2007) · low 1 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MBH

98in 2025

2007: 59 days median2008: 70 days median2009: 209 days median2010: 84 days median2011: 84 days median2012: 90 days median2013: 138 days median2014: 114 days median2015: 100 days median2016: 74 days median2017: 115 days median2018: 89 days median2020: 112 days median2021: 48 days median2022: 57 days median2023: 94 days median2024: 84 days median2025: 98 days median2026 (partial year): 153 days median
2007high 209 (2009) · low 48 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MBH

1in 2024

2009: 22011: 152012: 1, 1 Class I2013: 4, 4 Class I2016: 12017: 92018: 12019: 12020: 22023: 22024: 12026 (partial year): 4
2007high 15 (2011) · low 0 (2007)2026

Class I (5 since 2007) Class II/III not classified

Adverse event reports per year · MBH

1,561in 2025

2007: 272008: 212009: 892010: 1212011: 2472012: 3702013: 3082014: 3852015: 9552016: 1,0342017: 1,0072018: 1,1912019: 1,3942020: 1,0892021: 1,5392022: 1,2612023: 1,2632024: 1,4972025: 1,561
2007high 1,561 (2025) · low 21 (2008)2025

MAUDE reports naming product code MBH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071059027
2008370021
20093209289
20104840121
201158415247
20125901 (1)370
201361384 (4)308
201491140385
201581000955
201647411,034
2017411591,007
201868911,191
20191—11,394
2020711221,089
202164801,539
202275701,261
202369421,263
2024108411,497
202589801,561
202671534—

What is it indicated for?

The OPTETRAK Comprehensive Knee Systems are indicated for use in skeletally mature individuals undergoing primary surgery for total knee replacement due to osteoarthritis, osteonecrosis, rheumatoid arthritis and/or post-traumatic degenerative problems. They are also indicated for revision of failed previous reconstructions where sufficient bone stock and soft tissue integrity are present. In the USA, the OPTETRAK Comprehensive Knee Systems are indicated for cemented use only, except for the OPTETRAK Logic PS and CR Porous Femoral Components, which are indicated for cemented or cementless use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K140302: Optetrak Logic Porous Femoral Components.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K140302

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026